MEN 11467

Drug Profile

MEN 11467

Latest Information Update: 12 Apr 2000

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Menarini
  • Class Anti-inflammatories
  • Mechanism of Action Neurokinin 1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Gastrointestinal disorders; Glioma; Respiratory tract disorders

Most Recent Events

  • 12 Apr 2000 Discontinued-Preclinical for Gastrointestinal disorders in Italy (PO)
  • 12 Apr 2000 Discontinued-Preclinical for Glioma in Italy (Unknown route)
  • 12 Apr 2000 Discontinued-Preclinical for Respiratory tract disorders in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top